Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR

Avet-Loiseau, H; San-Miguel, J; Casneuf, T; Iida, S; Lonial, S; Usmani, SZ; Spencer, A; Moreau, P; Plesner, T; Weisel, K; Ukropec, J; Chiu, C; Trivedi, S; Amin, H; Krevvata, M; Ramaswami, P; Qin, X; Qi, M; Sun, S; Qi, M; Kobos, R; Bahlis, NJ

Avet-Loiseau, H (corresponding author), IUC Oncopole, Unite Genom Myelome, 1 Ave Irene Joliot Curie, F-31100 Toulouse, France.

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (10): 1139